- Home
- BANR vs KNSA Comparison
BANR vs KNSA Comparison
Compare BANR & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANR
- KNSA
- Stock Information
- Founded
- BANR 1890
- KNSA 2015
- Country
- BANR United States
- KNSA United Kingdom
- Employees
- BANR N/A
- KNSA N/A
- Industry
- BANR Major Banks
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- BANR Finance
- KNSA Health Care
- Exchange
- BANR Nasdaq
- KNSA Nasdaq
- Market Cap
- BANR 2.2B
- KNSA 2.1B
- IPO Year
- BANR 1995
- KNSA 2018
- Fundamental
- Price
- BANR $68.68
- KNSA $28.04
- Analyst Decision
- BANR Buy
- KNSA Strong Buy
- Analyst Count
- BANR 6
- KNSA 6
- Target Price
- BANR $70.40
- KNSA $39.33
- AVG Volume (30 Days)
- BANR 227.0K
- KNSA 1.1M
- Earning Date
- BANR 07-16-2025
- KNSA 07-22-2025
- Dividend Yield
- BANR 2.79%
- KNSA N/A
- EPS Growth
- BANR 5.82
- KNSA N/A
- EPS
- BANR 5.09
- KNSA N/A
- Revenue
- BANR $614,045,000.00
- KNSA $481,166,000.00
- Revenue This Year
- BANR $3.72
- KNSA $37.21
- Revenue Next Year
- BANR $5.38
- KNSA $5.32
- P/E Ratio
- BANR $13.49
- KNSA N/A
- Revenue Growth
- BANR 3.98
- KNSA 59.45
- 52 Week Low
- BANR $50.61
- KNSA $17.82
- 52 Week High
- BANR $78.05
- KNSA $30.69
- Technical
- Relative Strength Index (RSI)
- BANR 69.63
- KNSA 51.09
- Support Level
- BANR $66.34
- KNSA $27.06
- Resistance Level
- BANR $69.51
- KNSA $29.25
- Average True Range (ATR)
- BANR 2.10
- KNSA 0.97
- MACD
- BANR 0.46
- KNSA -0.06
- Stochastic Oscillator
- BANR 91.25
- KNSA 50.83
About BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.